Issue link: https://tmcpulse.uberflip.com/i/792366
t m c » p u l s e | m a r c h 2 0 1 7 32 One Hour with an LVAD Legend Heart pump pioneer O.H. "Bud" Frazier, M.D., leads monthly bedside teaching rounds A t 3:05 p.m. on a recent Tuesday, O.H. "Bud" Frazier, M.D., pushed through the double doors of the car- diovascular and thoracic surgery unit of Baylor St. Luke's Medical Center. Immediately, he went in search of some coffee. A large crowd had congregated to greet and learn from the man who is recognized as the leader in the development of left ventricular assist devices (LVADs). Last November, Frazier, chief of transplant services at Baylor St. Luke's, professor of surgery at Baylor College of Medicine and chief of the Center for Cardiac Support at the Texas Heart Institute, launched monthly one-hour bedside teaching rounds on LVADs. Students, interns, residents, fellows, nurse practitioners and physician assistants are invited to spend an hour with him. LVADs are the most widely-used heart pump. Over the past decade, an estimated 30,000 LVADs have been implanted in patients around the world. These electromechanical pumps, also called mechanical circulatory support devices, were developed by a handful of pioneering heart surgeons from the Texas Medical Center, including Frazier. "I studied the idea of LVADs for two years with Dr. Michael DeBakey because there were not enough hearts for trans- plants," Frazier explained. "Recently, I was in Kazakhstan, where they have implanted 400 pumps. Nobody thought that was possible to do." Frazier is a protégé of both DeBakey and Denton Cooley, M.D., but he blazed his own trail in clinical practice, research and teaching. He has performed more than 1,300 heart transplants and implanted close to 1,000 LVADs, outnumbering any other surgeon in the world, according to CHI St. Luke's Health. In 1986, Frazier performed the world's first implantation of HealthMate I, a pneumatically powered LVAD. In 2000, he implanted the Jarvik 2000 LVAD, a continuous-flow pump widely used as long-term support for patients who may not be candidates for transplants. Then in 2011, Frazier and William E. "Billy" Cohn, M.D., implanted the first total heart replace- ment with two continuous-flow pumps inside a human patient. During his teaching rounds, Frazier focused on a female patient whose first LVAD failed. Frazier spoke with the patient's care team and tried to determine what would cause the pump to stop working. Some people have had heart pumps for as long as 13 years without any issues, he explained. Frazier's continuous-flow pump design is different from older pulsatile pumps that mimic the healthy human heart and beat 100,000 times every 24 hours. The newer, non-pulsatile pumps produce a continuous flow of blood and are smaller and more durable without the parts needed to produce frequent pulses. "The pump works like a light that you turn on and off," Frazier explained. "If they are made properly, which this one was, it can't be the pump. It has to be something about the way it was implanted." The pump spins blood through the heart like coffee that is being stirred in a cup, he explained. It was designed flat so that it could be implanted on the right or the left side of the heart, but works best when placed on the diaphrag- matic surface of the heart—the interior surface that rests on the diaphragm. Dr. Frazier is briefed on the patient's status in the cardiovascular and thoracic surgery unit of Baylor St. Luke's Medical Center. He learns that the patient's first pump was implanted in 2013, but she came to the hospital in early 2017 feeling poorly. Her medical team replaced the pump. Frazier demonstrates the way blood is pushed in and out of the heart after a left ventricular assist device (LVAD) is implanted. 3:11 p.m. 3:26 p.m. >> >> B y C h r i s t i n e H a l l